picric acid has been researched along with oxazolone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asherson, GL; Blackstock, R; Zembala, M | 1 |
Boirivant, M; Fuss, IJ; Strober, W | 1 |
Elinav, E; Eshhar, Z; Waks, T | 1 |
de Zoeten, EF; Hancock, WW | 1 |
4 other study(ies) available for picric acid and oxazolone
Article | Year |
---|---|
Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). I. Picryl and oxazolone-specific TsF, which inhibit transfer of contact sensitivity, also inhibit phagocytosis by a subset of macrophages.
Topics: Alkylation; Animals; Antigens, Bacterial; Cryptococcus; Dermatitis, Contact; H-2 Antigens; Haptens; Immunization, Passive; Macrophages; Mice; Mice, Inbred Strains; Oxazolone; Oxidation-Reduction; Phagocytosis; Picrates; Polysaccharides, Bacterial; Suppressor Factors, Immunologic | 1991 |
Regulatory cells induced by feeding TNP-haptenated colonic protein cross-protect mice from colitis induced by an unrelated hapten.
Topics: Adjuvants, Immunologic; Administration, Oral; Animal Feed; Animals; Antigens; Colitis; Colon; Disease Models, Animal; Haptens; Interleukin-10; Male; Mice; Monocytes; Oxazolone; Picrates; Proteins; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid | 2005 |
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Topics: Animals; Bystander Effect; CD28 Antigens; Cell Line; Cell Movement; Colitis; Colon; Disease Models, Animal; Forkhead Transcription Factors; Histocompatibility Antigens; Immunity, Mucosal; Immunoglobulin Variable Region; Immunotherapy, Adoptive; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oxazolone; Picrates; Receptors, Antigen, T-Cell; Receptors, IgG; Recombinant Fusion Proteins; T-Lymphocytes, Regulatory; Time Factors; Trinitrobenzenesulfonic Acid | 2008 |
Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
Topics: Animals; Autoimmune Diseases; Bystander Effect; Cell Movement; Colitis; Colon; Disease Models, Animal; Forkhead Transcription Factors; Immunity, Mucosal; Immunotherapy, Adoptive; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Transgenic; Oxazolone; Picrates; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; T-Lymphocytes, Regulatory; Time Factors; Trinitrobenzenesulfonic Acid | 2008 |